Updated Quality Measurement Set for Parkinson Disease Treatment

Some simple quality measures aim to improve Parkinson disease care in the clinic setting.

Sponsoring Organization: American Academy of Neurology (AAN)

Target Audience: Clinicians who treat patients with Parkinson disease (PD), including movement disorder specialists, other neurologists, and primary care clinicians

Background and Objective

The AAN updated its 2010 measurement set based on new evidence of gaps in care for patients with PD and research showing opportunities to improve their care.

Key Recommendations

PD is the second most common neurodegenerative disorder. There is a pressing need to improve the quality of care delivered by neurologists and other healthcare practitioners to patients with PD. In 2010, the AAN published the first widely available quality measures on PD, designed to be used in the clinic setting. The idea o…

Reviewing Author

Michael S. Okun, MD

Disclosures

Consultant/Advisory BoardParkinson’s Foundation; Tourette Association of America

Speaker’s BureauMedscape/WebMD CME, Movement Disorders Society CME, American Academy of Neurology CME

RoyaltiesBooks4Patients; Demos; Cambridge; Taylor and Francis; Robert Rose; Public Affairs

Grant/Research SupportNational Institutes of Health; Parkinson’s Foundation; Tourette Association of America; University of Florida Foundation

Editorial BoardsTremor and Other Hyperkinetic Movements; JAMA Neurology

Leadership Positions in Professional SocietiesParkinson’s Foundation (Medical Advisor)